Report overview
Autoimmune disease is a condition in which the immune system is unable to recognize the body?s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Drug. This report contains market size and forecasts of Autoimmune Disease Drug in global, including the following market information:
Global Autoimmune Disease Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Autoimmune Disease Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Drug include Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, Roche and Biogen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autoimmune Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disease Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Type, 2022 (%)
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
Global Autoimmune Disease Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
Global Autoimmune Disease Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Autoimmune Disease Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autoimmune Disease Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autoimmune Disease Drug, market overview.
Chapter 2: Global Autoimmune Disease Drug market size in revenue.
Chapter 3: Detailed analysis of Autoimmune Disease Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autoimmune Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
